{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:35:27Z","timestamp":1765485327542},"reference-count":86,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.02.095","type":"journal-article","created":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T08:31:39Z","timestamp":1236760299000},"page":"2967-2980","source":"Crossref","is-referenced-by-count":46,"title":["A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Baseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sondra","family":"Perdue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.-Tien","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rochelle","family":"Shain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mabey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2009.02.095_bib1","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.4049\/jimmunol.138.9.3023","article-title":"Pathogenesis of trachoma: the stimulus for inflammation","volume":"138","author":"Taylor","year":"1987","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00007435-199007000-00001","article-title":"Sexually transmitted diseases and tubal pregnancy","volume":"17","author":"Sherman","year":"1990","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.095_bib3","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/humrep\/17.8.2073","article-title":"HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study","volume":"17","author":"Kinnunen","year":"2002","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.095_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007435-200205000-00001","article-title":"Epidemic lymphogranuloma venereum during epidemics of crack cocaine use and HIV infection in the Bahamas","volume":"29","author":"Bauwens","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.095_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.olq.0000168429.13282.c8","article-title":"Lymphogranuloma venereum: how to turn an endemic disease into an outbreak of a new disease? Start looking","volume":"32","author":"Schachter","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2009.02.095_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3201\/eid1111.050821","article-title":"Slow epidemic of lymphogranuloma venereum l2b strain","volume":"11","author":"Spaargaren","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2009.02.095_bib7","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/IAI.63.12.4704-4714.1995","article-title":"Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection","volume":"63","author":"Cotter","year":"1995","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib8","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/IAI.67.3.1379-1385.1999","article-title":"Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis","volume":"67","author":"Perry","year":"1999","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2009.02.095_bib9","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.02.095_bib10","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1128\/IAI.64.11.4830-4833.1996","article-title":"Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection","volume":"64","author":"Barteneva","year":"1996","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.095_bib11","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.67.4.1606-1613.1999","article-title":"Immunity to Chlamydia trachomatis mouse pneumonitis induced by vaccination with live organisms correlates with early granulocyte\u2013macrophage colony-stimulating factor and interleukin-12 production and with dendritic cell-like maturation","volume":"67","author":"Zhang","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.095_bib12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/IAI.67.4.1763-1769.1999","article-title":"Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection","volume":"67","author":"Lu","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cellimm.2004.09.002","article-title":"Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice","volume":"230","author":"Murthy","year":"2004","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.095_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/IAI.01064-07","article-title":"Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection","volume":"76","author":"Cheng","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.olq.0000148299.14513.11","article-title":"Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum","volume":"32","author":"Shah","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.095_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/infdis\/159.6.1105","article-title":"Experimental Chlamydia trachomatis salpingitis in mice: initial studies on the characterization of the leukocyte response to chlamydial infection","volume":"159","author":"Patton","year":"1989","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.095_bib17","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1128\/IAI.70.6.2741-2751.2002","article-title":"Immunity to murine chlamydial genital infection","volume":"70","author":"Morrison","year":"2002","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.02.095_bib18","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1073\/pnas.98.3.1160","article-title":"CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis","volume":"98","author":"Fling","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2009.02.095_bib20","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1128\/IAI.66.11.5457-5461.1998","article-title":"Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection","volume":"66","author":"Lampe","year":"1998","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.095_bib21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/nar\/28.6.1397","article-title":"Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39","volume":"28","author":"Read","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.095_bib22","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/nar\/gkg321","article-title":"Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae","volume":"31","author":"Read","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"5389","key":"10.1016\/j.vaccine.2009.02.095_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.282.5389.754","article-title":"Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis","volume":"282","author":"Stephens","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1369-5274(98)80146-X","article-title":"The diverse habitats of obligate intracellular parasites","volume":"1","author":"Hackstadt","year":"1998","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.02.095_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0966-842X(97)01061-5","article-title":"Origins and functions of the chlamydial inclusion","volume":"5","author":"Hackstadt","year":"1997","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0890-8508(02)00108-1","article-title":"Detection of type III secretion genes as a general indicator of bacterial virulence","volume":"17","author":"Stuber","year":"2003","journal-title":"Mol Cell Probes"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.095_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/MMBR.62.2.379-433.1998","article-title":"Type III protein secretion systems in bacterial pathogens of animals and plants","volume":"62","author":"Hueck","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5418","key":"10.1016\/j.vaccine.2009.02.095_bib28","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.284.5418.1322","article-title":"Type III secretion machines: bacterial devices for protein delivery into host cells","volume":"284","author":"Galan","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1462-5822.2000.00029.x","article-title":"A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane","volume":"2","author":"Bannantine","year":"2000","journal-title":"Cell Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/dnares\/10.1.9","article-title":"In silico inference of inclusion membrane protein family in obligate intracellular parasites chlamydiae","volume":"10","author":"Toh","year":"2003","journal-title":"DNA Res"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.095_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tim.2007.04.005","article-title":"Type III secretion a la Chlamydia","volume":"15","author":"Peters","year":"2007","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JB.01034-06","article-title":"Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements","volume":"189","author":"Hefty","year":"2007","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.095_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2958.1995.tb02371.x","article-title":"Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells","volume":"15","author":"Rockey","year":"1995","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1286-4579(02)01546-0","article-title":"Proteins in the chlamydial inclusion membrane","volume":"4","author":"Rockey","year":"2002","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.095_bib35","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1128\/IAI.00010-08","article-title":"Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome","volume":"76","author":"Li","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mib.2008.01.003","article-title":"Chlamydia effector proteins and new insights into chlamydial cellular microbiology","volume":"11","author":"Valdivia","year":"2008","journal-title":"Curr Opin Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.095_bib37","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/IAI.01377-07","article-title":"The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells","volume":"76","author":"Li","year":"2008","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.095_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1084\/jem.193.8.935","article-title":"Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors","volume":"193","author":"Zhong","year":"2001","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib39","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1365-2958.2001.02272.x","article-title":"Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery","volume":"39","author":"Subtil","year":"2001","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.095_bib40","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/j.1365-2958.2005.04647.x","article-title":"A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates","volume":"56","author":"Subtil","year":"2005","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.095_bib41","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1046\/j.1365-2958.2000.02212.x","article-title":"Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism","volume":"38","author":"Fields","year":"2000","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.095_bib42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/IAI.73.2.905-911.2005","article-title":"The Salmonella enterica serovar typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells","volume":"73","author":"Ho","year":"2005","journal-title":"Infect Immun"},{"issue":"39","key":"10.1016\/j.vaccine.2009.02.095_bib43","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1073\/pnas.0606412103","article-title":"A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis","volume":"103","author":"Muschiol","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.095_bib44","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1365-2958.2006.05347.x","article-title":"Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle","volume":"61","author":"Wolf","year":"2006","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.095_bib45","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/JB.01671-07","article-title":"Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis","volume":"190","author":"Betts","year":"2008","journal-title":"J Bacteriol"},{"issue":"18","key":"10.1016\/j.vaccine.2009.02.095_bib46","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1128\/JB.187.18.6466-6478.2005","article-title":"Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates","volume":"187","author":"Fields","year":"2005","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.095_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/JB.187.2.473-479.2005","article-title":"Interaction between components of the type III secretion system of Chlamydiaceae","volume":"187","author":"Slepenkin","year":"2005","journal-title":"J Bacteriol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.095_bib48","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/j.1462-5822.2007.00970.x","article-title":"Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model","volume":"9","author":"Chellas-Gery","year":"2007","journal-title":"Cell Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.02.095_bib49","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1084\/jem.189.12.1931","article-title":"Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1","volume":"189","author":"Zhong","year":"1999","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2009.02.095_bib50","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.191.9.1525","article-title":"Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells","volume":"191","author":"Zhong","year":"2000","journal-title":"J Exp Med"},{"issue":"27","key":"10.1016\/j.vaccine.2009.02.095_bib51","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1073\/pnas.0402829101","article-title":"A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin","volume":"101","author":"Clifton","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.095_bib52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.tim.2005.08.002","article-title":"Tyrosine-phosphorylated bacterial effector proteins: the enemies within","volume":"13","author":"Backert","year":"2005","journal-title":"Trends Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.02.095_bib53","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1128\/IAI.73.7.3860-3868.2005","article-title":"Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin","volume":"73","author":"Clifton","year":"2005","journal-title":"Infect Immun"},{"issue":"27","key":"10.1016\/j.vaccine.2009.02.095_bib54","doi-asserted-by":"crossref","first-page":"9947","DOI":"10.1073\/pnas.0403633101","article-title":"Tarp and Arp: how Chlamydia induces its own entry","volume":"101","author":"Engel","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"42","key":"10.1016\/j.vaccine.2009.02.095_bib55","doi-asserted-by":"crossref","first-page":"15599","DOI":"10.1073\/pnas.0603044103","article-title":"Chlamydial TARP is a bacterial nucleator of actin","volume":"103","author":"Jewett","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.095_bib56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2008.04.089","article-title":"Chlamydia trachomatis tarp is phosphorylated by src family tyrosine kinases","volume":"371","author":"Jewett","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib57","doi-asserted-by":"crossref","first-page":"e1000014","DOI":"10.1371\/journal.ppat.1000014","article-title":"Chlamydial entry involves TARP binding of guanine nucleotide exchange factors","volume":"4","author":"Lane","year":"2008","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.095_bib58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/IAI.72.1.451-460.2004","article-title":"Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis","volume":"72","author":"Greene","year":"2004","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2009.02.095_bib59","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.4049\/jimmunol.151.7.3728","article-title":"Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis","volume":"151","author":"Zhong","year":"1993","journal-title":"J Immunol"},{"issue":"25","key":"10.1016\/j.vaccine.2009.02.095_bib60","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1073\/pnas.94.25.13856","article-title":"Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein","volume":"94","author":"Zhong","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.095_bib61","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/IAI.62.5.1576-1583.1994","article-title":"Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis","volume":"62","author":"Zhong","year":"1994","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.02.095_bib62","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1128\/IAI.60.8.3143-3149.1992","article-title":"Antibody responses to the chlamydial heat shock proteins hsp60 and hsp70 are H-2 linked","volume":"60","author":"Zhong","year":"1992","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib63","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1128\/IAI.59.3.1141-1147.1991","article-title":"Antigenic determinants of the chlamydial major outer membrane protein resolved at a single amino acid level","volume":"59","author":"Zhong","year":"1991","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2009.02.095_bib64","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1128\/IAI.01119-06","article-title":"Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele","volume":"74","author":"Murthy","year":"2006","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.095_bib65","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/IAI.58.10.3438-3441.1990","article-title":"Immunoaccessible peptide sequences of the major outer membrane protein from Chlamydia trachomatis serovar C","volume":"58","author":"Zhong","year":"1990","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2009.02.095_bib66","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1128\/IAI.72.12.7164-7171.2004","article-title":"Human antibody responses to a Chlamydia-secreted protease factor","volume":"72","author":"Sharma","year":"2004","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib67","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1128\/IAI.01313-07","article-title":"Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor","volume":"76","author":"Cheng","year":"2008","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib68","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.174.3.1701","article-title":"B activation is not required for Chlamydia trachomatis inhibition of host epithelial cell apoptosis","volume":"174","author":"Xiao","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.095_bib69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.187.4.487","article-title":"Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation","volume":"187","author":"Fan","year":"1998","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.095_bib70","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1084\/jem.184.5.2061","article-title":"Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP)","volume":"184","author":"Zhong","year":"1996","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2009.02.095_bib71","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1128\/IAI.73.7.4414-4419.2005","article-title":"Inhibition of proteolytic activity of a chlamydial proteasome\/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis","volume":"73","author":"Sharma","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib72","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/IAI.73.3.1868-1872.2005","article-title":"Production of a proteolytically active protein, chlamydial protease\/proteasome-like activity factor, by five different Chlamydia species","volume":"73","author":"Dong","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib73","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1128\/IAI.73.3.1861-1864.2005","article-title":"Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells","volume":"73","author":"Dong","year":"2005","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.095_bib74","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.095_bib75","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1128\/IAI.00730-06","article-title":"Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection","volume":"74","author":"Imtiaz","year":"2006","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.095_bib76","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib77","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/IAI.74.3.1490-1499.2006","article-title":"Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins","volume":"74","author":"Sharma","year":"2006","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.095_bib78","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/IAI.57.4.1040-1049.1989","article-title":"Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars","volume":"57","author":"Yuan","year":"1989","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.095_bib79","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1128\/IAI.73.10.6407-6418.2005","article-title":"Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains","volume":"73","author":"Carlson","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.095_bib80","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1365-2958.2003.03462.x","article-title":"Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development","volume":"48","author":"Fields","year":"2003","journal-title":"Mol Microbiol"},{"issue":"14","key":"10.1016\/j.vaccine.2009.02.095_bib81","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1073\/pnas.1331135100","article-title":"Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis","volume":"100","author":"Belland","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2009.02.095_bib82","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2958.2000.02057.x","article-title":"Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle","volume":"37","author":"Shaw","year":"2000","journal-title":"Mol Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.02.095_bib83","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/IAI.63.12.4661-4668.1995","article-title":"Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection","volume":"63","author":"Morrison","year":"1995","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.095_bib84","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cellimm.2006.10.002","article-title":"The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells","volume":"242","author":"Murphey","year":"2006","journal-title":"Cell Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.02.095_bib85","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1086\/509507","article-title":"Human cytolytic T cell recognition of Yersinia pestis virulence proteins that target innate immune responses","volume":"194","author":"Saikh","year":"2006","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.095_bib86","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1348-0421.2008.00028.x","article-title":"The Bordetella type III secretion system: its application to vaccine development","volume":"52","author":"Abe","year":"2008","journal-title":"Microbiol Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:09:55Z","timestamp":1684922995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":86,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003673"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}